Phenotype and Genotype of Advanced Premalignant Head and Neck Lesions After Chemopreventive Therapy

Abstract

Our data suggest that clinical and histologic assessments of the response to chemopreventive agents may be insufficient to determine their efficacy and that critical genetic alterations could be used as independent biomarkers to augment the ability to evaluate the efficacy of such agents.